Company: INSP
Filing Date: 2025-08-04
Form Type: 10-Q
Source: 0001609550-25-000032
Chunk: 16

Company: Inspire Medical Systems, Inc.
Filing Date: 2025-08-04
Form: 10-Q
Item: Part I, Item 1
Chunk 16
---
)

Six Months Ended June 30, 2025Common StockSharesAmountAdditionalPaid-InCapitalAccumulatedOtherComprehensiveIncome (Loss)AccumulatedDeficitTotalStockholders'EquityBalance at December 31, 202429,740,176 $30 $981,043 $536 $(291,914)$689,695 Stock options exercised73,491 — 6,441 — — 6,441 Vesting of restricted stock units and performance stock units, net199,778 — (19,192)— — (19,192)Issuance of common stock390 — 69 — — 69 Stock-based compensation expense— — 31,056 — — 31,056 Accelerated share repurchase of common stock(103,886)— — — — — Share repurchase of common stock(442,649)(1)(75,008)— — (75,009)Other comprehensive loss— — — (309)— (309)Net income— — — — 2,992 2,992 Balance at March 31, 202529,467,300 29 924,409 227 (288,922)635,743 Stock options exercised43,691 — 2,174 — — 2,174 Vesting of restricted stock units and performance stock units, net28,487 — (1,732)— — (1,732)Issuance of common stock490 — 73 — — 73 Issuance of common stock for employee stock purchase plan29,509 — 3,255 — — 3,255 Stock-based compensation expense— — 41,724 — — 41,724 Other comprehensive income— — — 169 — 169 Net income— — — — (3,592)(3,592)Balance at June 30, 202529,569,477 $29 $969,903 $396 $(292,514)$677,814 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

7

Inspire Medical Systems, Inc.

Consolidated Statements of Stockholders' Equity (unaudited)

(in thousands, except share amounts)

Six Months